<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="833c7a0b-5f64-4363-94d5-9a179049113a"><labelDrug name="Tekturna"><Normalization><mmtx cui="C1870961" preferredWord="Tekturna" semType="phsu, orch"/></Normalization></labelDrug><generic name="aliskiren hemifumarate"/><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1" text="Drug Label for drug brand Tekturna, containing aliskiren hemifumarate." type="negative"><entity charOffset="26:34" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.0" text="tekturna" type="Biomedical_Entity"><Normalization><mmtx cui="C1870961" phraseText="Drug Label for drug brand Tekturna," preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="47:69" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.1" text="aliskiren hemifumarate" type="Biomedical_Entity"><Normalization><mmtx cui="C1879678" phraseText="aliskiren hemifumarate." preferredWord="aliskiren hemifumarate" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Tekturna," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.1"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.1.e.1"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.21" text="Tekturna may be administered with some other antihypertensive agents. " type="negative"><entity charOffset="0:8" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.21.e.0" text="tekturna" type="Biomedical_Entity"><Normalization><mmtx cui="C1870961" phraseText="Tekturna" preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="45:68" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.21.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.21.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.21.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22" lineNumber="33" text="In diabetics, do not use in combination with angiotensin receptor blockers (ARBs) or angiotensin converting enzyme inhibitors (ACEIs) see Contraindications (4). " type="irregular"><entity charOffset="14:24" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.0" text="do not use" type="Caution_Interaction"/><entity charOffset="3:12" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.2" text="diabetics" type="SPAN"/><entity charOffset="45:81" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.3" text="angiotensin receptor blockers (ARBs)" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="85:133" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.4" text="angiotensin converting enzyme inhibitors (ACEIs)" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors (ACEIs)" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.0"><relations><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.4"/></relation><relation type="hasObject"><labelDrug text="Tekturna"/><normalization><mmtx><preferredWord>Tekturna</preferredWord><phraseText>Tekturna</phraseText><cuiCode>C1870961</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.22.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23" lineNumber="33" text="Concomitant use of aliskiren with an ARB or ACEI is not recommended in patients with GFR 60 ml/min see Warnings and Precautions (5.2). " type="regular"><entity charOffset="19:28" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="Concomitant use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="37:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.1" text="ARB" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="44:48" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.2" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="71:88" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.3" text="patients with GFR" type="SPAN"/><entity charOffset="52:67" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.4" text="not recommended" type="Caution_Interaction"/><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.3" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.1" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.4" type="Caution_Interaction"/><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.3" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.2" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.4" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.23.e.2"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24" text="Most exposure to date is with diuretics, an angiotensin receptor blocker (valsartan) or a calcium channel blocker (amlodipine). " type="negative"><entity charOffset="74:83" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.0" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="(valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="115:125" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.1" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="(amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="90:113" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.2" text="calcium channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C3536851" phraseText="a calcium channel blocker" preferredWord="Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="44:55" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.3" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="an angiotensin receptor blocker" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.4" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="is with diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.1"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.2"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.4" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.1"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.1"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.4" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.1"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.2"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.4" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.2"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.4" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.3"/></sentence><sentence biomedicalEntities="1" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25" lineNumber="33" text="Aliskiren used together with these drugs has a greater effect at their maximum recommended doses than either drug alone. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24" Text="Most exposure to date is with diuretics, an angiotensin receptor blocker (valsartan) or a calcium channel blocker (amlodipine). "/><anaphoraEntity charOffset="29:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.1" text="these drugs" type="Expression"/><antecedentEntity charOffset="30:39" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.0" text="diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24" Text="Most exposure to date is with diuretics, an angiotensin receptor blocker (valsartan) or a calcium channel blocker (amlodipine). "/><anaphoraEntity charOffset="29:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.1" text="these drugs" type="Expression"/><antecedentEntity charOffset="74:83" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.2" text="valsartan" type="Drug"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24" Text="Most exposure to date is with diuretics, an angiotensin receptor blocker (valsartan) or a calcium channel blocker (amlodipine). "/><anaphoraEntity charOffset="29:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.1" text="these drugs" type="Expression"/><antecedentEntity charOffset="115:125" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.24.e.5" text="amlodipine" type="Drug"/></anaphoraRelation><entity charOffset="0:9" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.0" text="Aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="Aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="47:61|97:119" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.5" text="greater effect than either drug alone" type="Specific_Interaction"/><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.5"><relations><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.1" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.25.e.5" type="Specific_Interaction"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26" text="It is not known whether additive effects are present when Tekturna is used with angiotensin-converting enzyme inhibitors (ACEIs) or beta blockers (BB)." type="negative"><entity charOffset="80:120" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.0" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="used with angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="58:66" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.1" text="tekturna" type="Biomedical_Entity"><Normalization><mmtx cui="C1870961" phraseText="Tekturna" preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="132:145" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.2" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="122:127" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.3" text="aceis" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="(ACEIs" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.2"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.2"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.3"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.26.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30" lineNumber="38" text="Do not use aliskiren with ARBs or ACEIs in patients with diabetes see Warnings and Precautions (5.2), Clinical Studies (14.3)." type="regular"><entity charOffset="0:10" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.0" text="Do not use" type="Caution_Interaction"/><entity charOffset="11:20" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ARBs" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="26:30" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="34:39" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.4" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="57:65" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.5" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.0"><relations><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.5" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.0" type="Caution_Interaction"/><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.5" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.3" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31" lineNumber="39" text="Do not use with angiotensin receptor blockers (ARBs) or ACE inhibitors (ACEIs) in patients with diabetes (4)" type="irregular"><entity charOffset="0:10" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.0" text="Do not use" type="Caution_Interaction"/><entity charOffset="16:52" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.2" text="angiotensin receptor blockers (ARBs)" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="use with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="use with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="56:78" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.3" text="ACE inhibitors (ACEIs)" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors (ACEIs) in patients" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="96:104" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30" text="Do not use aliskiren with ARBs or ACEIs in patients with diabetes see Warnings and Precautions (5.2), Clinical Studies (14.3)."><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.30.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.31.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33" lineNumber="45" text="&lt;item&gt;Avoid concomitant use with ARBs or ACEIs in patients with renal impairment (GFR 60 mL/min) (5.2)." type="irregular"><entity charOffset="6:11" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="33:37" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.2" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="41:46" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.3" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="64:80" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.4"/></relation><relation type="hasObject"><labelDrug text="Tekturna"/><normalization><mmtx><preferredWord>Tekturna</preferredWord><phraseText>Tekturna</phraseText><cuiCode>C1870961</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.33.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45" lineNumber="58" text="Tekturna is contraindicated in patients with diabetes who are receiving ARBs or ACEIs because of the increased risk of renal impairment, hyperkalemia, and hypotension see Contraindications (4) and Clinical Studies (14.3)." type="regular"><entity charOffset="0:8" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0" text="Tekturna" type="Drug"><Normalization><mmtx cui="C1870961" phraseText="Tekturna" preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="12:27" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="45:53" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="12:27" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.4" text="contraindicated" type="SPAN"/><entity charOffset="72:76" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="80:85" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="119:135" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.7" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="ACEIs because of the increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="ACEIs because of the increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="137:149" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.9" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="155:166" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.11" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6"/></relation><relation type="hasSeverity"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.ddi.2"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.ddi.3"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.ddi.4"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6" severity="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.1" type="Caution_Interaction"/><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.3" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5" severity="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.5" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.45.e.6"/></sentence><sentence biomedicalEntities="3" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46" lineNumber="59" text="Avoid use of Tekturna with ARBs or ACEIs in patients with moderate renal impairment (GFR 60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:21" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.2" text="Tekturna" type="Drug"><Normalization><mmtx cui="C1870961" phraseText="use of Tekturna" preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="27:31" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="35:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.4" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="67:83" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.5" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with moderate renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with moderate renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.5" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.0" type="Caution_Interaction"/><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.5" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.3" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.46.e.4"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.48" text="This may occur at any time during treatment and has occurred in patients with and without a history of angioedema with ACE inhibitors or angiotensin receptor antagonists. " type="negative"><entity charOffset="137:169" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.48.e.0" text="angiotensin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor antagonists." preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="119:133" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.48.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.48.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.48.e.0"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.51" text="Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. " type="negative"><entity charOffset="180:195" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.51.e.0" text="corticosteroids" type="Biomedical_Entity"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="161:175" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.51.e.1" text="antihistamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0019590" phraseText="treatment with antihistamines" preferredWord="Histamine Antagonists" semType="phsu, orch"/><RxNorm RxCui="967"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.51.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.51.e.0"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54" text="In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with Tekturna. " type="negative"><entity charOffset="220:228" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.0" text="tekturna" type="Biomedical_Entity"><Normalization><mmtx cui="C1870961" phraseText="with Tekturna." preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="139:148" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="those receiving high doses of diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.54.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" lineNumber="64" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). " type="regular"><entity charOffset="233:236" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0" text="ARB" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="238:242" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="246:285" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2" text="non-steroidal anti-inflammatory (NSAID)" type="Drug_Class"><Normalization><mmtx cui="C0003209" phraseText="non-steroidal anti-inflammatory (NSAID) therapy" preferredWord="Anti-Inflammatory Agents" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="335:354" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.3" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="for developing acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="358:366" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5" text="Tekturna" type="Drug"><Normalization><mmtx cui="C1870961" phraseText="on Tekturna" preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2"/></sentence><sentence biomedicalEntities="0" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60" lineNumber="64" text="Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function." type="irregular"><entity charOffset="9:20" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.0" text="withholding" type="Caution_Interaction"/><entity charOffset="24:37" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.2" text="discontinuing" type="Caution_Interaction"/><entity charOffset="95:121" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.4" text="decrease in renal function" type="Specific_Interaction"/><entity charOffset="49:121" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.6" text="patients who develop a clinically significant decrease in renal function" type="SPAN"/><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.0"><relations><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.6"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.ddi.2"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.2"><relations><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.6"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.ddi.3"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.60.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekturna see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.3). "><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.59.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61" text="Monitor serum potassium periodically in patients receiving Tekturna. " type="negative"><entity charOffset="14:23" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Monitor serum potassium periodically in patients" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61.e.1" text="tekturna" type="Biomedical_Entity"><Normalization><mmtx cui="C1870961" phraseText="Tekturna." preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63" lineNumber="65" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes, combination use with ARBs or ACEIs see Contraindications (4), Warnings and Precautions (5.2), and Clinical Studies (14.3), NSAIDs, or potassium supplements or potassium sparing diuretics." type="irregular"><entity charOffset="36:48" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.0" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="109:113" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="117:122" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="211:217" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="222:243" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="247:274" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics." preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61" text="Monitor serum potassium periodically in patients receiving Tekturna. "><entity charOffset="59:67" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.61.e.0" text="Tekturna" type="Drug"><Normalization><mmtx cui="C1870961" phraseText="Tekturna." preferredWord="Tekturna" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.62" text="Drugs that affect the renin-angiotensin system can cause hyperkalemia. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.63.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64" lineNumber="66" text="When aliskiren was given with cyclosporine or itraconazole, the blood concentrations of aliskiren were significantly increased. " type="regular"><entity charOffset="64:84|117:126" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.0" text="blood concentrations increased" type="Increase_Interaction"/><entity charOffset="30:42" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="given with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="46:58" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.3" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="88:97" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="the blood concentrations of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><mmtx cui="C1120110" phraseText="the blood concentrations of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.0" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.64.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65" lineNumber="66" text="Avoid concomitant use of aliskiren with cyclosporine or itraconazole see Drug Interactions (7)." type="regular"><entity charOffset="0:5" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="25:34" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="concomitant use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="40:52" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.3" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="56:68" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.4" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.0"><relations><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.3" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.4" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.65.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67" lineNumber="70" text="Cyclosporin e : Avoid co-administration of cyclosporine with aliskiren." type="regular"><entity charOffset="43:55" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.0" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="co-administration of cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.1" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="with aliskiren." preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="16:21" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.2" text="Avoid" type="Caution_Interaction"/><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.0" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.1" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.67.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68" lineNumber="71" text="Itraconazole : Avoid co-administration of itraconazole with aliskiren See Clinical Pharmacology (12.3)." type="regular"><entity charOffset="15:20" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="42:54" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.2" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="co-administration of itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="60:69" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="with aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.0"><relations><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.3" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.68.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69" lineNumber="72" text="Non-Steroidal Anti-Inflammatory Agents (NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors with agents that affect the renin-angiotensin system, including aliskiren, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="136:143" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.0" text="elderly" type="SPAN"/><entity charOffset="145:160" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="208:234" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="257:263" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="275:301" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors with agents" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="307:354" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.5" text="agents that affect the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="selective COX-2 inhibitors with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the renin-angiotensin system," preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="366:375" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.6" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren," preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="391:422" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="443:462" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.4"/><drugClassMembership drug="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.6" drugClass="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.5"/><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.9"><relations><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.ddi.2"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.11"><relations><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.0, Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.2, Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.1" ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.3" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.5" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.69.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71" lineNumber="72" text="Monitor renal function periodically in patients receiving aliskiren and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.3" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.71.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72" lineNumber="73" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs." type="regular"><entity charOffset="4:27|48:58" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.0" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="31:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="The antihypertensive effect of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="62:68" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.3" trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73" lineNumber="76" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)." type="irregular"><entity charOffset="20:25" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="6:18" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73.e.2" text="Cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="&gt;Cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs."><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74" lineNumber="78" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)" type="irregular"><entity charOffset="20:25" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="6:18" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74.e.2" text="Itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="&gt;Itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs."><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2"/></ellipsisSentence><middleSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75" lineNumber="80" text="&lt;item&gt;NSAIDs use may lead to increased risk of renal impairment and loss of antihypertensive effect (7)" type="irregular"><entity charOffset="47:63" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.0" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="lead to increased risk of renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="lead to increased risk of renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="68:99" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.2" text="loss of antihypertensive effect" type="Specific_Interaction"/><entity charOffset="6:12" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.ddi.1"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs."><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2"/></ellipsisSentence><middleSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.ddi.2"><interaction trigger="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs."><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.72.e.2"/></ellipsisSentence><middleSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.73" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.74" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.75.e.4"/></sentence><sentence id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77" text="Tekturna contains aliskiren hemifumarate, a renin inhibitor, that is provided as tablets for oral administration. " type="negative"><entity charOffset="44:59" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.0" text="renin inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3537174" phraseText="a renin inhibitor," preferredWord="Renin Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="9246"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.1" text="tekturna" type="Biomedical_Entity"><Normalization><mmtx cui="C1870961" phraseText="Tekturna" preferredWord="Tekturna" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="18:40" id="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.2" text="aliskiren hemifumarate" type="Biomedical_Entity"><Normalization><mmtx cui="C1879678" phraseText="aliskiren hemifumarate," preferredWord="aliskiren hemifumarate" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.2" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.0"/><pair ddi="false" e1="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.1" e2="Dailymed.833c7a0b-5f64-4363-94d5-9a179049113a.s.77.e.2"/></sentence><positiveExamples number="35"/><negativeExamples number="50"/></document>